2 ms·
I think the elephant in the room is not He's work, but the fact that embryonic selection is already commercially available from Steve Hsu's Genomic Prediction[1
by s1artibartfast 6y ago
I think the elephant in the room is not He's work, but the fact that embryonic selection is already commercially available from Steve Hsu's Genomic Prediction[1] and other companies.
It doesn't impart new genes, so it can't give HIV immunity if the parents don't have it, but it can screen large numbers of embryos and allow the parents to select the one(s) they want based on their genetic makeup
It is done using well established technology and can select the factors that people really care about: intelligence, and freedom from disease, gender, and mental health.
Genomic Predictions is already working with 200 IVF clinics and screening millions of embryos a year. Many countries have laws against using the technology to screen for anything but disease (e.g. higher intelligence), but some do not.
https://pitchbook.com/profiles/company/228085-75#overview https://pitchbook.com/profiles/company/228085-75#overview
- est31 6y agoCreating multiple embryos in the lab then screening them for diseases etc. can of course help with some situations, but if both chromosomes from one parent carry some variant of a gene, you can't get rid of it. Similarly, you can't introduce desired variants if none of the two parents want them. So arbitrary edits are way more powerful.
- s1artibartfast 6y agoI think powerful is a loaded word, but the rest of what you said is correct. They are different technologies for different things. Crispr is "good" for single genes. Screening is "good" for polygenic traits. For example, intelligence is thought to be linked to over 500 genes. This would not be good target for embryonic editing, even if the error rate was extremely low.